SOR-C13 Uses, Dosage, Side Effects and more
SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel).
| Trade Name | SOR-C13 |
| Generic | SOR-C13 |
| Type | |
| Formula | C72H116N20O19 |
| Weight | Average: 1565.841 Monoisotopic: 1564.872561595 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
